EMA Recommends Bluevac-3 and Syvazul BTV 3 Vaccine...
Category : Approval/Launch 21 January 2025EMA has recommended the approval of the vaccines Bluevac-3 and Syvazul BTV 3 to protect sheep agains...
Approval Launch
FDA Approves Zydus’ Phase IIb trial of Usnoflast f...
Category : Approval/Launch 21 January 2025The trial will test 50mg and 75mg doses of the therapy against a placebo. he US Food and Drug Admini...
Health Canada Approves MedMira’s Reveal G4 Rapid H...
Category : Approval/Launch 16 January 2025MedMira Inc. (MedMira) announced that it has received the approval from Health Canada for its Reveal...
Eton Pharma Acquires Galzin, FDA-Approved Treatmen...
Category : Approval/Launch 7 January 2025Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercial...
Capricor Seeks FDA Approval for Deramiocel to Trea...
Category : Approval/Launch 6 January 2025Capricor Therapeutics, a biotechnology company developing transformative cell and exosome-based ther...
Latest Newsletter Post
-
FDA Approves Zydus’ Phase IIb trial..
21 January 2025
-
Fermion & Simcere Partner to Develo..
21 January 2025
-
EMA Recommends Bluevac-3 and Syvazu..
21 January 2025
-
Teva Partners with Formycon to Comm..
16 January 2025
-
Vivoryon Strengthens R&D Pipeline f..
16 January 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com